21 June 2016

Prospero House, 241 Borough High Street, London

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

1. Welcome and introduction to format of meeting

2. Apologies

3. Any other business 

4. Minutes from the last Committee meeting held on 17 May 2016

5. Appraisal of Secukinumab for treating ankylosing spondylitis after inadequate response to non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors

5.1 Declarations of interest - Part 1 only (open session)

5.2 Introduction by Chair, Dr Jane Adam - Part 1 (open session)

5.3 Presentation by the Lead Team, Dr Anne McCune, Dr Brian Shine and Miss Pamela Rees - Part 1 and Part 2 (open and closed session)

5.4  Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

6.  Appraisal of Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer [ID767]

 6.1 Declarations of interest - Part 1 (open session)

6.2 Introduction by Chair, Dr Jane Adam - Part 1 (open session)

6.3 Presentation by the Chair, Dr Jane Adam – Part 1 and Part 2 (open and closed session)

6.4  Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

7. Appraisal of Talimogene laherparepvec for treating metastatic melanoma [ID508]

 7.1 Declarations of interest - Part 1 (open session)

7.2 Introduction by Chair, Dr Jane Adam - Part 1 (open session)

7.3 Presentation by the Chair, Dr Jane Adam – Part 1 and Part 2 (open and closed session)

7.4  Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

 Date, time and venue of next meeting 

Next Technology Appraisal (Committee A) Meeting:  Tuesday 19 July, 10:00, venue: TBC

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is 7 June 2016. Please note that it may not be possible to accept late registration requests.

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Joshua South.

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

 

 

 

 

 

Registration period: 23 May 2016 to 07 June 2016
Registration is closed.